维罗纳制药 VRNA 深 沪
等待开盘 10-18 09:30:00 美东时间
106.91
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 106.91
- 总市值 91.93亿
- 52周最高 106.93
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 31.60
- 委 比 0.00%
- 总股本 8599.13万
- 历史最高 106.93
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.01
- 每 手 1
- 风险率 5.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多1.2万亿美元！强生、罗氏引领全球制药并购火力竞赛
（来源：医趋势） 进入2025年，全球制药行业的并购周期正在重新被点燃。专利悬崖逼近、创新竞争白热化、资本回流药企主业，叠加AI研发与新赛道崛起——资金雄厚的...
10-10 11:12
BD不BD，给个痛快吧
本文来自格隆汇专栏：阿基米德Biotech BD预期已形成堰塞湖。 恒生生物科技指数（HSHKBIO）在节日期间上涨3.7%，重燃创新药二次行情的希望，但在节后...
10-10 08:16
Next CDC AdCom meeting on vaccines delayed
The Centers for Disease Control and Prevention (CDC) has postponed an October meeting of its Advisory Committee on Immunization Practices (ACIP), an expert panel whose views are critical in the rollou...
10-09 19:17
1.2万亿美元！全球药企“氪金”榜单刷新！大扫货开始了
（来源：求实药社） 进入2025年，全球制药行业的并购周期正在重新被点燃。专利悬崖逼近、创新竞争白热化、资本回流药企主业，叠加AI研发与新赛道崛起——资金雄厚的...
10-09 12:05
Merck acquisition of Verona Pharma approved by court
Merck's (NYSE:MRK) ~$10B acquisition of Verona Pharma (NASDAQ:VRNA) has been granted approval by the High Court of Justice of England and Wales. Under terms, MSD, the trade name of Merck outside the U...
10-07 04:46
Verona Pharma Announces That High Court Of Justice Of England And Wales Has Approved Its Acquisition By MSD For $107 Per American Depository Share, Totaling ~$10B
Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to its proposed acquisition by MSD
10-07 04:07
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
Verona Pharma plc announced that the High Court of England and Wales has approved its acquisition by MSD for $107 per ADS, totaling approximately $10 billion. The transaction will close on October 7, 2025, upon the delivery of the Court Order to the Registrar of Companies. Trading of Verona ADSs on Nasdaq is expected to halt before October 7, 2025. The acquisition is implemented through a Court-sanctioned scheme of arrangement under English law.
10-06 20:05
利空突袭！深夜，暴跌89%！
突然“爆雷”！ 周一美股，市值近40亿美元（约合人民币285亿元）的生物技术公司MoonLake暴跌89%。此前，该公司发布的一款实验性皮肤病药物的Ⅲ期...
09-29 22:47
Verona Pharma Receives Shareholders Approval For Proposed Acquisition by Merck
LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive
09-25 04:11
